UNITED STATES
SECURITIES EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. )*

China Medical Technologies Inc.
(Name of Issuer)

American Depositary Receipt
(Title of Class of Securities)

169483104
(CUSIP Number)

September 14, 2009
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

[ ] Rule 13d-1(b)

[X] Rule 13d-1(c)

[ ] Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Continued on following pages Page 1 of 5 Pages

SCHEDULE 13G 

CUSIP No.: 169483104 Page 2 of 5 Pages
................................................................................

1. Names of Reporting Persons.

 I.R.S. Identification Nos. of above persons (entities only).


 NORGES BANK (THE CENTRAL BANK OF NORWAY)
................................................................................
2. Check the Appropriate Box if a Member of a Group

 (a) [ ]

 (b) [ ] N/A
................................................................................

3. SEC Use Only
................................................................................

4. Citizenship or Place of Organization

 NORWAY
................................................................................

Number of 5. Sole Voting Power 1,626,530
Shares
Beneficially ................................................................
Owned by Each
Reporting 6. Shared Voting Power 0
Person With ................................................................

 7. Sole Dispositive Power 30,041
 ................................................................

 8. Shared Dispositive Power 0
................................................................................

9. Aggregate Amount Beneficially Owned by Each Reporting Person

 1,626,530
................................................................................

10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
 Instructions)

 N/A
................................................................................

11. Percent of Class Represented by Amount in Row (9)

 5.07% based on 32,106,666 American Depositary Receipts issued
................................................................................

12. Type of Reporting Person:

 OO


CUSIP No.: 169483104 Page 3 of 5 Pages


Item 1(a). Name of Issuer:

 China Medical Technologies Inc. (the "Issuer").

Item 1(b). Address of Issuer's Principal Executive Offices:
 24 Yong Chang North Road
 Beijing Economic-Technological Development Area
 Beijing 100176, Republic of China

Item 2(a). Name of Person Filing:

 This Statement is filed on behalf of each of the following
 persons (collectively, the "Reporting Persons"):

 NORGES BANK (CENTRAL BANK OF NORWAY)

Item 2(b). Address of Principal Business Office or, if None, Residence:
 Bankplassen 2
 PO Box 1179 Sentrum
 NO 0107 Oslo
 Norway

Item 2(c). Citizenship:
 Norwegian

Item 2(d). Title of Class of Securities:

 American Depositary Receipt

Item 2(e). CUSIP Number:

 169483104

Item 3. If This Statement is Filed Pursuant to ss.ss.240.13d-1(b) or
 240.13d-2(b) or (c),

 Check Whether the Person Filing is a:

 This Item 3 is not applicable.

Item 4. Ownership:

Item 4(a) Amount Beneficially Owned

 As of September 14, 2009, Norges Bank may be deemed to be the
 benficial owner of 1,626,530 shares of American Depositary Receipt.

Item 4(b) Percent of Class:

 The number of Shares which Norges Bank may be deemed to be the
 beneficial owner constitutes approximately 5.07% of the total
 number of American Depositary Receips outstanding (based upon
 information provided by the Issuer in its most recently filed quarterly
 report), there is 32,106,666 shares of American Depositary
 Receipts outstanding). All shares held by Norges Bank are in the form
 of American Depositary Receipts, each representing 10 ordinary shares.

Page 4 of 5 Pages

Item 4(c) Number of Shares of which such person has:

NORGES BANK (CENTRAL BANK OF NORWAY)

(i) Sole power to vote or direct the vote: 1,626,530

(ii) Shared power to vote or direct the vote: 0

(iii) Sole power to dispose or direct the disposition of: 30,041

(iv) Shared power to dispose or direct the disposition of: 0

Item 5. Ownership of Five Percent or Less of a Class:

This Item 5 is not applicable.

Item 6. Ownership of More than Five Percent on Behalf of Another
Person:

This Item 6 is not applicable.

Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding Company:

This Item 7 is not applicable.

Item 8. Identification and Classification of Members of the Group:

This Item 8 is not applicable.

Item 9. Notice of Dissolution of Group:

This Item 9 is not applicable.

Item 10. Certification:

By signing below each of the Reporting Persons certifies that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Page 5 of 5 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

NORGES BANK 

Date: September 18, 2009
 By: /s/ Jonas Lexmark
 ----------------------
 Name: Jonas Lexmark
 Title: Analyst

China Medical (NASDAQ:CMED)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more China Medical Charts.
China Medical (NASDAQ:CMED)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more China Medical Charts.